Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Gene

AI Reveals Critical Alzheimer’s Gene and Promising Treatment Options

May 17, 2025
NVIDIA Acquires GPU Orchestration Software Provider Run:ai for $700 Million

AI Breakthrough in Alzheimer’s Research: The Key Role of Gene PHGDH By James Ding May 16, 2025 03:52 In an exciting leap for Alzheimer’s research, scientists at the University of California, San Diego (UCSD) have … Read more

Categories Economy Tags Alzheimers, critical, Gene, options, Promising, Reveals, Treatment

Bionexus Gene Lab Partners with ML Tech

March 8, 2025
Bionexus Gene Lab enters partnership with ML Tech

BioNexus Gene Lab Partners with ML Tech to Fortify Ethereum Investment Strategies In the ever-evolving landscape of cryptocurrency and decentralized finance, strategic partnerships can play a pivotal role in optimizing growth and maximizing returns. Recently, … Read more

Categories Finance Tags Bionexus, Gene, Lab, Partners, Tech

Bluebird Bio’s Gene Therapy Attracts Interest from Carlyle and SK Capital

February 21, 2025
Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

The Fall of Bluebird Bio: What It Means for the Future of Gene Therapy Investments The world of biotechnology is often filled with towering highs and devastating lows, and recent news about Bluebird Bio epitomizes … Read more

Categories Business News Tags Attracts, Bios, Bluebird, Capital, Carlyle, Gene, Interest, Therapy

Eli Lilly to Make Bold Moves in Alzheimer’s, ALS, and Gene Therapy Research

February 20, 2025
Eli Lilly to take big swings in Alzheimer's, ALS and gene therapy

Eli Lilly: Ambitious Approaches in the Battle Against Major Health Challenges Eli Lilly, buoyed by the success of its GLP-1 medications, including Mounjaro and Zepbound, is on a mission to tackle some of the most … Read more

Categories Business News Tags ALS, Alzheimers, Bold, Eli, Gene, Lilly, moves, Research, Therapy

Sickle Cell Gene Therapies Drive Health Plans to Explore Innovative Payment Models

February 19, 2025
Sickle cell gene therapies push health plans toward new payment models

# Transforming Lives: The Breakthrough of Sickle Cell Gene Therapies At Extreme Investor Network, we believe in staying at the forefront of the latest developments in health and finance. And right now, the landscape of … Read more

Categories Business News Tags cell, Drive, Explore, Gene, health, innovative, Models, payment, plans, Sickle, Therapies

Sangamo Therapeutics Shares Tumble After Pfizer Cancels Hemophilia Gene Therapy Agreement

December 31, 2024
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

Sangamo Therapeutics Faces Instability After Pfizer’s Sudden Exit The financial landscape is often influenced by collaborations and partnerships in the pharmaceutical sector. A recent turn of events has sent Sangamo Therapeutics, Inc. (NASDAQ: SGMO) stock … Read more

Categories Finance Tags agreement, cancels, Gene, hemophilia, Pfizer, Sangamo, Shares, Therapeutics, Therapy, Tumble

Late-stage trial of Pfizer’s gene therapy proves successful in treating hemophilia A

July 24, 2024
Pfizer's gene therapy for hemophilia A succeeds in late-stage trial

Revolutionizing Treatment for Hemophilia A: Pfizer’s Breakthrough Gene Therapy Kena Betancur | Corbis News | Getty Images At Extreme Investor Network, we are excited to share the latest groundbreaking news in the field of gene … Read more

Categories Business News Tags Gene, hemophilia, latestage, Pfizers, proves, successful, Therapy, treating, Trial

AI Model Geneformer Harnesses Gene Networks with Restricted Data Access

July 15, 2024
NVIDIA Acquires GPU Orchestration Software Provider Run:ai for $700 Million

Unlocking Gene Networks and Disease Mechanisms with Geneformer AI Model By Extreme Investor Network Published on Jul 15, 2024 14:38 Geneformer, a revolutionary AI model developed by researchers at the Broad Institute of MIT and … Read more

Categories Economy Tags access, data, Gene, Geneformer, Harnesses, Model, Networks, Restricted

Citi predicts surge of over 45% for shares of gene editing company

May 19, 2024
Shares of this gene editing company due to surge more than 45%, Citi says

At Extreme Investor Network, we strive to provide you with up-to-date and valuable information on investing opportunities that can help you make informed decisions to grow your portfolio. Today, we are excited to discuss the … Read more

Categories Investing Tags Citi, Company, editing, Gene, predicts, Shares, surge

Pfizer’s gene therapy Beqvez approved by FDA for hemophilia B treatment

April 26, 2024
FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

Introducing Pfizer’s Breakthrough Gene Therapy for Hemophilia B: Beqvez At Extreme Investor Network, we are always on the lookout for groundbreaking developments in the world of business and healthcare. That’s why we are excited to … Read more

Categories Business News Tags approved, Beqvez, FDA, Gene, hemophilia, Pfizers, Therapy, Treatment
Older posts
Page1 Page2 Next →

Categories

Recent Posts

  • AI Reveals Critical Alzheimer’s Gene and Promising Treatment OptionsMay 17, 2025
  • Chinese Firms Explore Singapore Listings to Broaden Markets Amid Trade TensionsMay 17, 2025
  • Gold Price Prediction: Anticipated Dip to $2,800 Before Reaching New PeaksMay 17, 2025
  • These Stocks, Including UnitedHealth, Were the Most Oversold This WeekMay 17, 2025
  • NVIDIA’s cuEmbed Enhances GPU Performance for Embedding SearchesMay 17, 2025
  • Trump Criticizes Walmart’s Consumer Warning—But Your Wallet May Still Feel the ImpactMay 17, 2025
  • Nasdaq Index: Optimistic Outlook as Adobe, Alphabet, and AMD Drive Weekly Stock Market GainsMay 17, 2025
  • Five “High-Quality” Stocks with Significant Upside, According to Bank of AmericaMay 17, 2025
  • Bitcoin (BTC) Soars to $104K as Spot Market Takes the LeadMay 17, 2025
  • Expert Insights: Essential Tips for Navigating Market Uncertainty and Managing Your Retirement SavingsMay 17, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights
Next Page »